Obtaining the most relevant and robust data from cells and model systems necessitates the right combination of assays and instrumentation for the biological question at hand. Selecting the wrong instrumentation can significantly impact the accuracy and efficiency of your drug development workflow.
It is important to consider factors such as sensitivity, selectivity, throughput, and return on investment when choosing instrumentation for tasks such as target identification, hit validation, and lead optimization. The use of appropriate analytics such as capillary electrophoresis, cell counters, plate readers, high-content screening systems and in vivo imaging systems can help you make informed decisions and accelerate the drug discovery process.
近年來，爱游戏平台注册登录 公司專注於臨床前分子影像技術的研究和開發。2010-2011年，爱游戏平台注册登录 公司在陸續收購VisEn Medical、CRi和Caliper（Xenogen）公司後，已經擁有FMT和IVIS小動物活體成像平台，此外，憑借雄厚的技術儲備和科研實力，爱游戏平台注册登录 公司近年來陸續推出了兼具高分辨率和快速低輻射掃描的活體離體二合一小動物microCT成像係統、業內最高靈敏度的小動物PET/CT成像係統和先進的臨床前小動物手術導航係統。現在，爱游戏平台注册登录 公司已經成為臨床前分子影像技術的全球領導者和最大供應商。 在爱游戏平台注册登录 ，我們已經為 ...
